TY - JOUR AU - Baxter, E. J. AU - Scott, L. M. AU - Campbell, P. J. AU - East, C. AU - Fourouclas, N. AU - Swanton, S. PY - 2005 DA - 2005// TI - Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)74230-6 DO - 10.1016/S0140-6736(05)74230-6 ID - Baxter2005 ER - TY - JOUR AU - James, C. AU - Ugo, V. AU - Le Couedic, J. P. AU - Staerk, J. AU - Delhommeau, F. AU - Lacout, C. PY - 2005 DA - 2005// TI - A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera JO - Nature VL - 434 UR - https://doi.org/10.1038/nature03546 DO - 10.1038/nature03546 ID - James2005 ER - TY - JOUR AU - Kralovics, R. AU - Passamonti, F. AU - Buser, A. S. AU - Teo, S. S. AU - Tiedt, R. AU - Passweg, J. R. PY - 2005 DA - 2005// TI - A gain-of-function mutation of JAK2 in myeloproliferative disorders JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa051113 DO - 10.1056/NEJMoa051113 ID - Kralovics2005 ER - TY - JOUR AU - Levine, R. L. AU - Wadleigh, M. AU - Cools, J. AU - Ebert, B. L. AU - Wernig, G. AU - Huntly, B. J. PY - 2005 DA - 2005// TI - Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis JO - Cancer Cell VL - 7 UR - https://doi.org/10.1016/j.ccr.2005.03.023 DO - 10.1016/j.ccr.2005.03.023 ID - Levine2005 ER - TY - JOUR AU - Kralovics, R. AU - Teo, S. S. AU - Buser, A. S. AU - Brutsche, M. AU - Tiedt, R. AU - Tichelli, A. PY - 2005 DA - 2005// TI - Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-05-1889 DO - 10.1182/blood-2005-05-1889 ID - Kralovics2005 ER - TY - JOUR AU - Schwemmers, S. AU - Will, B. AU - Waller, C. F. AU - Abdulkarim, K. AU - Johansson, P. AU - Andreasson, B. PY - 2007 DA - 2007// TI - JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling JO - Exp Hematol VL - 35 UR - https://doi.org/10.1016/j.exphem.2007.07.004 DO - 10.1016/j.exphem.2007.07.004 ID - Schwemmers2007 ER - TY - JOUR AU - Puigdecanet, E. AU - Espinet, B. AU - Lozano, J. J. AU - Sumoy, L. AU - Bellosillo, B. AU - Arenillas, L. PY - 2008 DA - 2008// TI - Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia JO - Leukemia VL - 22 UR - https://doi.org/10.1038/leu.2008.112 DO - 10.1038/leu.2008.112 ID - Puigdecanet2008 ER - TY - JOUR AU - Vannucchi, A. M. AU - Guglielmelli, P. AU - Tefferi, A. PY - 2009 DA - 2009// TI - Advances in understanding and management of myeloproliferative neoplasms JO - CA Cancer J Clin VL - 59 UR - https://doi.org/10.3322/caac.20009 DO - 10.3322/caac.20009 ID - Vannucchi2009 ER - TY - JOUR AU - Tefferi, A. PY - 2008 DA - 2008// TI - Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy JO - Am J Hematol VL - 83 UR - https://doi.org/10.1002/ajh.21183 DO - 10.1002/ajh.21183 ID - Tefferi2008 ER - TY - JOUR AU - Verstovsek, S. AU - Mesa, R. A. AU - Gotlib, J. AU - Levy, R. S. AU - Gupta, V. AU - DiPersio, J. F. PY - 2012 DA - 2012// TI - A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1110557 DO - 10.1056/NEJMoa1110557 ID - Verstovsek2012 ER - TY - JOUR AU - Mesa, R. A. AU - Gotlib, J. AU - Gupta, V. AU - Catalano, J. V. AU - Deininger, M. W. AU - Shields, A. L. PY - 2013 DA - 2013// TI - Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.4489 DO - 10.1200/JCO.2012.44.4489 ID - Mesa2013 ER - TY - JOUR AU - Issaq, H. AU - Veenstra, T. PY - 2008 DA - 2008// TI - Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives JO - Biotechniques VL - 44 UR - https://doi.org/10.2144/000112823 DO - 10.2144/000112823 ID - Issaq2008 ER - TY - JOUR AU - Marubayashi, S. AU - Koppikar, P. AU - Taldone, T. AU - Abdel-Wahab, O. AU - West, N. AU - Bhagwat, N. PY - 2010 DA - 2010// TI - HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans JO - J Clin Invest VL - 120 UR - https://doi.org/10.1172/JCI42442 DO - 10.1172/JCI42442 ID - Marubayashi2010 ER - TY - JOUR AU - Schmitt, E. AU - Parcellier, A. AU - Gurbuxani, S. AU - Cande, C. AU - Hammann, A. AU - Morales, M. C. PY - 2003 DA - 2003// TI - Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant JO - Cancer Res VL - 63 ID - Schmitt2003 ER - TY - JOUR AU - Dix, D. J. AU - Allen, J. W. AU - Collins, B. W. AU - Mori, C. AU - Nakamura, N. AU - Poorman-Allen, P. PY - 1996 DA - 1996// TI - Targeted gene disruption of Hsp70-2 results in failed meiosis, germ cell apoptosis, and male infertility JO - Proc Natl Acad Sci U S A VL - 93 UR - https://doi.org/10.1073/pnas.93.8.3264 DO - 10.1073/pnas.93.8.3264 ID - Dix1996 ER - TY - JOUR AU - Zermati, Y. AU - Garrido, C. AU - Amsellem, S. AU - Fishelson, S. AU - Bouscary, D. AU - Valensi, F. PY - 2001 DA - 2001// TI - Caspase activation is required for terminal erythroid differentiation JO - J Exp Med VL - 193 UR - https://doi.org/10.1084/jem.193.2.247 DO - 10.1084/jem.193.2.247 ID - Zermati2001 ER - TY - JOUR AU - Schmitt, E. AU - Gehrmann, M. AU - Brunet, M. AU - Multhoff, G. AU - Garrido, C. PY - 2007 DA - 2007// TI - Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy JO - J Leukoc Biol VL - 81 UR - https://doi.org/10.1189/jlb.0306167 DO - 10.1189/jlb.0306167 ID - Schmitt2007 ER - TY - JOUR AU - Song, J. AU - Takeda, M. AU - Morimoto, R. I. PY - 2001 DA - 2001// TI - Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth JO - Nat Cell Biol VL - 3 UR - https://doi.org/10.1038/35060068 DO - 10.1038/35060068 ID - Song2001 ER - TY - JOUR AU - Gotz, R. AU - Kramer, B. W. AU - Camarero, G. AU - Rapp, U. R. PY - 2004 DA - 2004// TI - BAG-1 haplo-insufficiency impairs lung tumorigenesis JO - BMC Cancer VL - 4 UR - https://doi.org/10.1186/1471-2407-4-85 DO - 10.1186/1471-2407-4-85 ID - Gotz2004 ER - TY - JOUR AU - Barrio, S. AU - Gallardo, M. AU - Arenas, A. AU - Ayala, R. AU - Rapado, I. AU - Rueda, D. PY - 2013 DA - 2013// TI - Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm JO - Br J Haematol VL - 161 UR - https://doi.org/10.1111/bjh.12308 DO - 10.1111/bjh.12308 ID - Barrio2013 ER - TY - JOUR AU - Beere, H. M. AU - Wolf, B. B. AU - Cain, K. AU - Mosser, D. D. AU - Mahboubi, A. AU - Kuwana, T. PY - 2000 DA - 2000// TI - Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35019501 DO - 10.1038/35019501 ID - Beere2000 ER - TY - JOUR AU - Ebong, I. O. AU - Morgner, N. AU - Zhou, M. AU - Saraiva, M. A. AU - Daturpalli, S. AU - Jackson, S. E. PY - 2011 DA - 2011// TI - Heterogeneity and dynamics in the assembly of the heat shock protein 90 chaperone complexes JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1106261108 DO - 10.1073/pnas.1106261108 ID - Ebong2011 ER - TY - JOUR AU - Sims, J. D. AU - McCready, J. AU - Jay, D. G. PY - 2011 DA - 2011// TI - Extracellular heat shock protein (Hsp)70 and Hsp90alpha assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0018848 DO - 10.1371/journal.pone.0018848 ID - Sims2011 ER - TY - JOUR AU - Schevchenko, V. A. AU - Akayeva, E. A. AU - Yeliseyeva, I. M. AU - Yelisova, T. V. AU - Yofa, E. L. AU - Nilova, I. N. PY - 1996 DA - 1996// TI - Human cytogenetic consequences of the Chernobyl accident JO - Mutat Res VL - 361 UR - https://doi.org/10.1016/S0165-1161(96)90226-5 DO - 10.1016/S0165-1161(96)90226-5 ID - Schevchenko1996 ER - TY - JOUR AU - Quintas-Cardama, A. AU - Vaddi, K. AU - Liu, P. AU - Manshouri, T. AU - Li, J. AU - Scherle, P. A. PY - 2010 DA - 2010// TI - Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-04-214957 DO - 10.1182/blood-2009-04-214957 ID - Quintas-Cardama2010 ER - TY - JOUR AU - Lambert, J. R. AU - Everington, T. AU - Linch, D. C. AU - Gale, R. E. PY - 2009 DA - 2009// TI - In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-03-209916 DO - 10.1182/blood-2009-03-209916 ID - Lambert2009 ER - TY - JOUR AU - Kralovics, R. AU - Teo, S. S. AU - Li, S. AU - Theocharides, A. AU - Buser, A. S. AU - Tichelli, A. PY - 2006 DA - 2006// TI - Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2005-11-009605 DO - 10.1182/blood-2005-11-009605 ID - Kralovics2006 ER - TY - JOUR AU - Levine, R. L. AU - Belisle, C. AU - Wadleigh, M. AU - Zahrieh, D. AU - Lee, S. AU - Chagnon, P. PY - 2006 DA - 2006// TI - X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-09-3900 DO - 10.1182/blood-2005-09-3900 ID - Levine2006 ER - TY - JOUR AU - Nussenzveig, R. H. AU - Swierczek, S. I. AU - Jelinek, J. AU - Gaikwad, A. AU - Liu, E. AU - Verstovsek, S. PY - 2007 DA - 2007// TI - Polycythemia vera is not initiated by JAK2V617F mutation JO - Exp Hematol VL - 35 UR - https://doi.org/10.1016/j.exphem.2006.11.012 DO - 10.1016/j.exphem.2006.11.012 ID - Nussenzveig2007 ER - TY - JOUR AU - Beer, P. A. AU - Jones, A. V. AU - Bench, A. J. AU - Goday-Fernandez, A. AU - Boyd, E. M. AU - Vaghela, K. J. PY - 2009 DA - 2009// TI - Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones JO - Br J Haematol VL - 144 UR - https://doi.org/10.1111/j.1365-2141.2008.07560.x DO - 10.1111/j.1365-2141.2008.07560.x ID - Beer2009 ER - TY - JOUR AU - Li, S. AU - Kralovics, R. AU - De Libero, G. AU - Theocharides, A. AU - Gisslinger, H. AU - Skoda, R. C. PY - 2008 DA - 2008// TI - Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-09-111971 DO - 10.1182/blood-2007-09-111971 ID - Li2008 ER - TY - JOUR AU - Delhommeau, F. AU - Dupont, S. AU - Della Valle, V. AU - James, C. AU - Trannoy, S. AU - Masse, A. PY - 2009 DA - 2009// TI - Mutation in TET2 in myeloid cancers JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0810069 DO - 10.1056/NEJMoa0810069 ID - Delhommeau2009 ER - TY - JOUR AU - Murphy, M. E. PY - 2013 DA - 2013// TI - The HSP70 family and cancer JO - Carcinogenesis VL - 34 UR - https://doi.org/10.1093/carcin/bgt111 DO - 10.1093/carcin/bgt111 ID - Murphy2013 ER - TY - JOUR AU - Parganas, E. AU - Wang, D. AU - Stravopodis, D. AU - Topham, D. J. AU - Marine, J. C. AU - Teglund, S. PY - 1998 DA - 1998// TI - Jak2 is essential for signaling through a variety of cytokine receptors JO - Cell VL - 93 UR - https://doi.org/10.1016/S0092-8674(00)81167-8 DO - 10.1016/S0092-8674(00)81167-8 ID - Parganas1998 ER - TY - JOUR AU - Tefferi, A. AU - Litzow, M. R. AU - Pardanani, A. PY - 2011 DA - 2011// TI - Long-term outcome of treatment with ruxolitinib in myelofibrosis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMc1109555 DO - 10.1056/NEJMc1109555 ID - Tefferi2011 ER -